Santaris Pharma's Convertible Note Round

Santaris Pharma raised a round of funding on June 22, 2012.

Santaris Pharma is a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies. The LNA Drug Platform and Drug Discovery Engine developed by Santaris …

Articles about Santaris Pharma's Convertible Note Round: